The Promise of Digital Biopsy for the Prediction of Tumor Molecular Features and Clinical Outcomes Associated With Immunotherapy

Immunotherapy by immune checkpoint inhibitors has emerged as an effective treatment for a slight proportion of patients with aggressive tumors. Currently, some molecular determinants, such as the expression of the programmed cell death ligand-1 (PD-L1) or the tumor mutational burden (TMB) have been...

Descripción completa

Detalles Bibliográficos
Autores principales: Banna, Giuseppe Luigi, Olivier, Timothée, Rundo, Francesco, Malapelle, Umberto, Fraggetta, Filippo, Libra, Massimo, Addeo, Alfredo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685050/
https://www.ncbi.nlm.nih.gov/pubmed/31417906
http://dx.doi.org/10.3389/fmed.2019.00172

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6685050/
https://www.ncbi.nlm.nih.gov/pubmed/31417906
http://dx.doi.org/10.3389/fmed.2019.00172

Ejemplares similares